U.S. approves new Merck drug for rare skin cancer
549819
Merck & Co Inc. won U.S. approval  for a new drug to treat a rare and slow-growing skin cancer  called advanced cutaneous T-cell lymphoma (CTCL), health  officials said on Friday.
205305
Federal health advisers on Wednesday recommended approval of the first new cancer drug in the past decade specifically aimed at treating the most common childhood leukemia.
112717
The US Food and Drug Administration Friday said it had approved Tarceva (erlotinib) tablets for patients with metastatic lung cancer.
581540
A new needle-free way is developed to deliver treatment to skin cancer patients, researchers say.
56445
WEDNESDAY, Jan. 16 (HealthDay News) -- A new genetic test that helps assess the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer has been approved by the U.S. Food and Drug Administration.
191767
THURSDAY, Feb 10 (HealthDay News) -- A compound derived from a rare South American plant shows promise as a treatment for breast cancer, according to a University of Virginia Health System study.
566278
Merck & Co Inc's Gardasil, the first  vaccine to prevent cervical cancer, has been approved for sale  in the Europe Union, the joint venture that will market the  product in Europe said on Friday.
643182
NEW YORK - Last night, the US Food and Drug Administration approved Tarceva, a pill that extends survival in advanced non-small-cell lung cancer patients for whom chemotherapy has failed.
466963
The Food and Drug Administration Friday approved a new drug designed to treat the leading cause of blindness in older Americans.
518874
WEDNESDAY, Sept. 29 (HealthDayNews) -- The anti-cancer drug Gleevec, highly touted for slowing the progression of chronic myeloid leukemia, also appears to stall a rare kind of skin cancer, a new study finds.
524945
The US Food and Drug Administration has granted fast-trackapproval to Tarceva (erlotinib) to treat advanced non-small cell lungcancer that has failed to respond to other therapy.
189561
US regulators said Tuesday they approved a new cancer drug from Genzyme Corp. for treating a type of childhood leukemia. The Food and Drug Administration, in a statement on its
518382
A new drug that fights a form of age-related macular degeneration (AMD), a leading cause of blindness in the elderly, won applause if not approval from a panel of advisors to the US Food and Drug Administration.
554059
A second-line drug to treat a life-threatening form of leukemia has won federal approval, the Food and Drug Administration said Monday.
380448
Biotech company OSI Pharmaceuticals Inc. and biotech giant Genentech Inc. reported Friday that the Food and Drug Administration approved their Tarceva cancer treatment for patients with advanced non-small-cell
246171
GlaxoSmithKline Plc won U.S. approval for a once-a-day breast cancer pill on Tuesday that the drugmaker hopes will launch a new era for its oncology business.
669994
US researchers have discovered a new virus they believe may be linked to a rare but extremely lethal type of skin cancer, a study released Thursday said.